Barclays’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-90,000
Closed -$3.93M 5323
2025
Q1
$3.93M Buy
+90,000
New +$3.92M ﹤0.01% 2100

Other funds holding DBD

Barclays's DBD Position: Q1 2026 in Review

Barclays reduced its Diebold Nixdorf (DBD) stake by 81% in Q1 2026, selling an estimated $2.3M and leaving 7,294 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #3141.

Barclays first reported a position in DBD in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.34M in Q2 2024. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Barclays held 7,294 shares of Diebold Nixdorf worth $550K as of Q1 2026.
  • Barclays sold 31,278 Diebold Nixdorf shares in Q1 2026, an estimated $2.3M.
  • Diebold Nixdorf made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3141 holding.
  • Barclays first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 10 quarters since.
  • Barclays's Diebold Nixdorf position peaked at $8.34M in Q2 2024.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.